Charles Riv­er to make Cas­gevy; Rentschler ex­tends col­lab with ‘ma­jor client’; An­de­lyn works with Ul­tragenyx

Wel­come to End­points News’ man­u­fac­tur­ing news briefs, where we bring you es­sen­tial up­dates on new builds, col­lab­o­ra­tions, re­calls and more.

Charles Riv­er Lab­o­ra­to­ries said Mon­day it will man­u­fac­ture Ver­tex and CRISPR Ther­a­peu­tics’ Cas­gevy, with its Mem­phis site hav­ing gone through au­dits by the FDA and EMA. CD­MO RoslinCT al­so man­u­fac­tures the gene edit­ing ther­a­py.

CD­MO Rentschler Bio­phar­ma said that it has a “ma­jor client” for its man­u­fac­tur­ing site in Mil­ford, MA, with the fa­cil­i­ty set to go live in the sec­ond half of next year. The man­u­fac­tur­er not­ed Wednes­day it will pro­duce its “long­stand­ing” client’s clin­i­cal-stage pro­tein ther­a­peu­tic for can­cer in the US, af­ter pre­vi­ous­ly pro­duc­ing the same as­set in Laupheim, Ger­many, for ear­ly-phase in­ves­ti­ga­tion.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER